Regulation 81 Amendment of regulation 72 (sale etc of suspended medicinal product)I1F1
United Kingdom
In regulation 72(1), for “regulation 69 or 70(2) or Article 20(4) of Regulation (EC) No 726/2004” substitute—
“—
(a)in the case of a medicinal product authorised for sale or supply by a UKMA(GB), regulation 69;
(b)in the case of a medicinal product authorised for sale or supply by a UKMA(NI) or UKMA(UK), regulation 69 or Article 20(4) of Regulation (EC) No 726/2004.”.
Annotations
Textual amendments
- F1
Reg. 81 substituted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 59
Commencement
- I1
Reg. 81 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1